ArticleFrontiers in medicine2023

The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma.

Malak Sabbah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.